$2.67 Billion is the total value of Tekla Capital Management LLC's 204 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 18.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | Sell | Amgen Inc. | $154,585,000 | +7.1% | 608,218 | -0.6% | 5.79% | +5.4% |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $116,092,000 | -1.0% | 207,388 | +10.4% | 4.35% | -2.5% |
| VRTX | Sell | Vertex Pharmaceuticals Inc. | $109,218,000 | -21.2% | 401,360 | -15.9% | 4.09% | -22.4% |
| GILD | Buy | Gilead Sciences, Inc. | $103,864,000 | -14.6% | 1,643,683 | +4.0% | 3.89% | -15.9% |
| MRK | Buy | Merck & Co., Inc. | $87,654,000 | +16.7% | 1,056,706 | +8.8% | 3.28% | +14.9% |
| ILMN | Buy | Illumina, Inc. | $86,868,000 | +9.3% | 281,054 | +30.9% | 3.26% | +7.6% |
| JNJ | Sell | Johnson & Johnson | $81,408,000 | -30.3% | 546,805 | -34.1% | 3.05% | -31.3% |
| ABBV | Buy | AbbVie Inc. | $76,617,000 | +46.2% | 874,720 | +63.9% | 2.87% | +44.0% |
| SGEN | Buy | Seagen Inc. | $65,987,000 | +61.4% | 337,204 | +40.2% | 2.47% | +58.9% |
| PFE | Buy | Pfizer Inc. | $62,235,000 | +14.9% | 1,695,768 | +2.4% | 2.33% | +13.1% |
| BIIB | Sell | Biogen Inc. | $60,637,000 | -3.0% | 213,753 | -8.5% | 2.27% | -4.5% |
| UNH | Sell | Unitedhealth Group Inc. | $57,907,000 | -29.9% | 185,735 | -33.7% | 2.17% | -31.0% |
| BMY | Sell | Bristol Myers Squibb Co. | $56,982,000 | -0.9% | 945,140 | -3.3% | 2.14% | -2.4% |
| MDT | Buy | Medtronic plcshares | $55,588,000 | +27.5% | 534,914 | +12.5% | 2.08% | +25.5% |
| HZNP | Buy | Horizon Therapeutics plcshares | $46,894,000 | +105.7% | 603,684 | +47.2% | 1.76% | +102.4% |
| ABT | Sell | Abbott Laboratories | $40,221,000 | -9.5% | 369,573 | -24.0% | 1.51% | -10.9% |
| HUM | Buy | Humana Inc. | $35,597,000 | +89.3% | 86,007 | +77.3% | 1.33% | +86.3% |
| SYK | Sell | Stryker Corp. | $32,887,000 | +11.1% | 157,830 | -3.9% | 1.23% | +9.4% |
| MRNA | Sell | Moderna, Inc. | $32,570,000 | +3.0% | 460,359 | -6.5% | 1.22% | +1.3% |
| BDX | Buy | Becton, Dickinson and Co. | $30,649,000 | +64.7% | 131,723 | +69.4% | 1.15% | +62.3% |
| ALXN | Sell | Alexion Pharmaceuticals, Inc. | $30,529,000 | -29.3% | 266,791 | -30.7% | 1.14% | -30.4% |
| SRPT | Buy | Sarepta Therapeutics, Inc. | $28,997,000 | +29.1% | 206,487 | +47.4% | 1.09% | +27.1% |
| BSX | Buy | Boston Scientific Corp. | $28,325,000 | +25.1% | 741,296 | +14.9% | 1.06% | +23.1% |
| EXEL | Buy | Exelixis, Inc. | $26,776,000 | +20.8% | 1,095,117 | +17.3% | 1.00% | +18.8% |
| CNC | Buy | Centene Corp. | $26,733,000 | +46.0% | 458,313 | +59.0% | 1.00% | +43.8% |
| LLY | Sell | Eli Lilly and Co. | $26,294,000 | -22.6% | 177,637 | -14.1% | 0.98% | -23.8% |
| ZBH | Buy | Zimmer Biomet Holdings, Inc. | $26,130,000 | +131.3% | 191,937 | +102.8% | 0.98% | +127.7% |
| ALNY | Buy | Alnylam Pharmaceuticals, Inc. | $25,465,000 | +36.6% | 174,894 | +39.0% | 0.95% | +34.4% |
| BMRN | Buy | BioMarin Pharmaceutical Inc. | $24,789,000 | -18.1% | 325,822 | +32.8% | 0.93% | -19.4% |
| EW | Buy | Edwards Lifesciences Corp. | $23,240,000 | +66.4% | 291,155 | +44.0% | 0.87% | +63.7% |
| CVS | Sell | CVS Health Corp. | $22,675,000 | -51.5% | 388,263 | -46.0% | 0.85% | -52.2% |
| STE | Buy | STERIS plcshares | $22,337,000 | +1197.9% | 126,779 | +1030.1% | 0.84% | +1168.2% |
| WAT | Buy | Waters Corp. | $21,429,000 | +219.5% | 109,510 | +194.5% | 0.80% | +214.9% |
| ASND | Buy | Ascendis Pharma A/Ssponsored adr | $19,405,000 | +128.2% | 125,746 | +118.8% | 0.73% | +124.4% |
| SNY | Buy | Sanofisponsored adr | $19,161,000 | +14.7% | 381,920 | +16.7% | 0.72% | +12.9% |
| IMMU | Sell | Immunomedics, Inc. | $18,990,000 | +7.8% | 223,336 | -55.1% | 0.71% | +6.1% |
| AZN | Buy | AstraZeneca PLCsponsored adr | $18,869,000 | +51.9% | 344,333 | +46.7% | 0.71% | +49.5% |
| XRAY | Buy | DENTSPLY SIRONA Inc. | $17,863,000 | +151.4% | 408,473 | +153.3% | 0.67% | +147.8% |
| ISRG | Sell | Intuitive Surgical, Inc. | $17,787,000 | -6.4% | 25,069 | -24.8% | 0.67% | -7.7% |
| RMD | Buy | ResMed Inc. | $16,641,000 | +386.0% | 97,069 | +444.4% | 0.62% | +380.0% |
| ARGX | Buy | argenx SEsponsored adr | $16,194,000 | +59.9% | 61,687 | +37.2% | 0.61% | +57.3% |
| MCK | McKesson Corp. | $16,015,000 | -2.9% | 107,537 | 0.0% | 0.60% | -4.5% | |
| BPMC | Buy | Blueprint Medicines Corp. | $15,761,000 | +70.9% | 170,018 | +43.8% | 0.59% | +68.4% |
| MYL | Mylan N.V.shares | $14,989,000 | -7.8% | 1,010,754 | 0.0% | 0.56% | -9.2% | |
| DHR | Sell | Danaher Corp. | $14,549,000 | -48.4% | 67,567 | -57.6% | 0.54% | -49.2% |
| INCY | Sell | Incyte Corp. | $13,695,000 | -59.5% | 152,605 | -53.1% | 0.51% | -60.1% |
| IDXX | Sell | IDEXX Laboratories, Inc. | $13,686,000 | +12.0% | 34,814 | -5.9% | 0.51% | +10.3% |
| LH | Buy | Laboratory Corporation of America Holdingssponsored adr | $13,179,000 | +67.9% | 70,003 | +48.2% | 0.49% | +65.2% |
| NVS | Sell | Novartis AGsponsored adr | $13,177,000 | -11.8% | 151,525 | -11.4% | 0.49% | -13.0% |
| GH | Buy | Guardant Health, Inc. | $13,173,000 | +99.4% | 117,852 | +44.7% | 0.49% | +96.8% |
| MRTX | Mirati Therapeutics, Inc. | $13,082,000 | +45.4% | 78,784 | 0.0% | 0.49% | +43.3% | |
| TMO | Sell | Thermo Fisher Scientific Inc. | $13,008,000 | -66.1% | 29,461 | -72.2% | 0.49% | -66.7% |
| NVCR | Sell | NovoCure Ltd.ordinary shares | $13,006,000 | +66.6% | 116,845 | -11.2% | 0.49% | +64.0% |
| IQV | IQVIA Holdings Inc. | $12,968,000 | +11.1% | 82,266 | 0.0% | 0.49% | +9.5% | |
| TECH | Bio-Techne Corp. | $12,810,000 | -6.2% | 51,710 | 0.0% | 0.48% | -7.7% | |
| DGX | Buy | Quest Diagnostics Inc. | $12,555,000 | +424.0% | 109,659 | +421.6% | 0.47% | +416.5% |
| CI | Sell | Cigna Corp. | $12,069,000 | -19.6% | 71,241 | -10.9% | 0.45% | -20.8% |
| ARNA | Buy | Arena Pharmaceuticals, Inc. | $12,014,000 | +116.9% | 160,637 | +82.5% | 0.45% | +113.3% |
| WELL | Welltower Inc. | $11,188,000 | +6.5% | 203,083 | 0.0% | 0.42% | +4.8% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $10,343,000 | -14.9% | 250,743 | 0.0% | 0.39% | -16.2% | |
| HCA | Sell | HCA Healthcare, Inc. | $10,215,000 | +25.5% | 81,933 | -2.3% | 0.38% | +23.5% |
| ANTM | Sell | Anthem, Inc. | $9,974,000 | -5.8% | 37,133 | -7.7% | 0.37% | -7.2% |
| BAX | Baxter International Inc. | $9,813,000 | -6.6% | 122,023 | 0.0% | 0.37% | -8.0% | |
| JAZZ | Jazz Pharmaceuticals plcshares | $9,619,000 | +29.2% | 67,456 | 0.0% | 0.36% | +27.2% | |
| MTD | Buy | Mettler-Toledo International Inc. | $9,464,000 | +91.9% | 9,800 | +60.1% | 0.36% | +88.8% |
| GRTX | Galera Therapeutics, Inc. | $9,418,000 | +26.6% | 1,041,845 | 0.0% | 0.35% | +24.7% | |
| ZTS | Sell | Zoetis Inc.class a | $9,347,000 | -15.9% | 56,521 | -30.3% | 0.35% | -17.3% |
| NVO | Novo Nordisk A/Ssponsored adr | $9,304,000 | +6.0% | 134,005 | 0.0% | 0.35% | +4.5% | |
| OHI | Omega Healthcare Investors, Inc. | $9,175,000 | +0.7% | 306,433 | 0.0% | 0.34% | -0.9% | |
| IONS | Ionis Pharmaceuticals, Inc. | $9,167,000 | -19.5% | 193,201 | 0.0% | 0.34% | -20.7% | |
| IOVA | Iovance Biotherapeutics, Inc. | $8,924,000 | +19.9% | 271,073 | 0.0% | 0.33% | +18.0% | |
| DOC | Physicians Realty Trust | $8,879,000 | +2.2% | 495,733 | 0.0% | 0.33% | +0.6% | |
| VTR | Ventas, Inc. | $8,732,000 | +14.6% | 208,108 | 0.0% | 0.33% | +12.8% | |
| FATE | Buy | Fate Therapeutics, Inc. | $8,692,000 | +36.5% | 217,462 | +17.1% | 0.33% | +34.7% |
| BGNE | Sell | BeiGene, Ltd.sponsored adr | $8,101,000 | -42.7% | 28,280 | -62.3% | 0.30% | -43.5% |
| PRAH | Sell | PRA Health Sciences, Inc. | $8,067,000 | -42.2% | 79,526 | -44.6% | 0.30% | -43.1% |
| RARE | Ultragenyx Pharmaceutical Inc. | $8,012,000 | +5.1% | 97,480 | 0.0% | 0.30% | +3.4% | |
| FGEN | FibroGen, Inc. | $7,988,000 | +1.4% | 194,270 | 0.0% | 0.30% | -0.3% | |
| CCXI | New | ChemoCentryx, Inc. | $7,916,000 | – | 144,447 | +100.0% | 0.30% | – |
| ABC | AmerisourceBergen Corp. | $7,816,000 | -3.8% | 80,645 | 0.0% | 0.29% | -5.2% | |
| MOH | Buy | Molina Healthcare, Inc. | $7,810,000 | +59.4% | 42,669 | +55.0% | 0.29% | +56.7% |
| DXCM | Buy | DexCom, Inc. | $7,644,000 | +160.0% | 18,544 | +155.7% | 0.29% | +155.4% |
| RETA | Buy | Reata Pharmaceuticals, Inc.class a | $7,447,000 | -6.2% | 76,440 | +50.2% | 0.28% | -7.6% |
| MPW | Medical Properties Trust, Inc. | $7,259,000 | -6.2% | 411,743 | 0.0% | 0.27% | -7.8% | |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $7,081,000 | -26.9% | 785,851 | 0.0% | 0.26% | -28.2% | |
| SBRA | Sabra Health Care REIT, Inc. | $7,039,000 | -4.5% | 510,660 | 0.0% | 0.26% | -5.7% | |
| CRL | Buy | Charles River Laboratories International, Inc. | $6,964,000 | +116.3% | 30,754 | +66.5% | 0.26% | +112.2% |
| GMAB | Buy | Genmab A/Ssponsored ads | $6,765,000 | +1108.0% | 184,779 | +1018.5% | 0.25% | +1109.5% |
| AGIO | Agios Pharmaceuticals, Inc. | $6,544,000 | -34.6% | 186,964 | 0.0% | 0.24% | -35.7% | |
| APLS | Buy | Apellis Pharmaceuticals, Inc. | $6,517,000 | +15.0% | 216,017 | +24.5% | 0.24% | +13.0% |
| STRO | Sutro Biopharma, Inc. | $6,445,000 | +29.5% | 641,268 | 0.0% | 0.24% | +28.0% | |
| UTHR | United Therapeutics Corp.class b | $6,415,000 | -16.5% | 63,513 | 0.0% | 0.24% | -17.8% | |
| CRSP | CRISPR Therapeutics AGnamen akt | $6,375,000 | +13.8% | 76,222 | 0.0% | 0.24% | +12.2% | |
| Trillium Therapeutics Inc. | $6,367,000 | +75.6% | 448,049 | 0.0% | 0.24% | +73.2% | ||
| LTC | LTC Properties, Inc. | $6,355,000 | -7.5% | 182,293 | 0.0% | 0.24% | -8.8% | |
| NBIX | Sell | Neurocrine Biosciences, Inc. | $6,078,000 | -75.8% | 63,203 | -69.3% | 0.23% | -76.2% |
| ZGNX | Buy | Zogenix, Inc. | $5,978,000 | +2.8% | 333,402 | +54.8% | 0.22% | +1.4% |
| CERN | Cerner Corp. | $5,892,000 | +5.5% | 81,500 | 0.0% | 0.22% | +3.8% | |
| TFX | Teleflex Inc. | $5,873,000 | -6.5% | 17,252 | 0.0% | 0.22% | -7.9% | |
| SAGE | Sage Therapeutics, Inc. | $5,880,000 | +47.0% | 96,211 | 0.0% | 0.22% | +44.7% | |
| FOLD | Buy | Amicus Therapeutics, Inc. | $5,727,000 | +12.7% | 405,626 | +20.4% | 0.22% | +11.4% |
| XNCR | Xencor, Inc. | $5,750,000 | +19.8% | 148,231 | 0.0% | 0.22% | +17.5% | |
| SYNH | Syneos Health, Inc.class a | $5,741,000 | -8.7% | 108,001 | 0.0% | 0.22% | -10.0% | |
| A | Agilent Technologies, Inc. | $5,302,000 | +14.2% | 52,525 | 0.0% | 0.20% | +12.4% | |
| ALLK | Allakos Inc. | $5,245,000 | +13.3% | 64,397 | 0.0% | 0.20% | +11.9% | |
| BCEL | Atreca, Inc. | $4,923,000 | -34.4% | 352,424 | 0.0% | 0.18% | -35.4% | |
| PKI | PerkinElmer, Inc. | $4,831,000 | +27.9% | 38,494 | 0.0% | 0.18% | +25.7% | |
| AMED | Amedisys, Inc. | $4,586,000 | +19.1% | 19,395 | 0.0% | 0.17% | +17.0% | |
| BLUE | bluebird bio, Inc. | $4,542,000 | -11.6% | 84,194 | 0.0% | 0.17% | -13.3% | |
| AUPH | Buy | Aurinia Pharmaceuticals Inc. | $4,428,000 | +200.2% | 300,611 | +231.1% | 0.17% | +196.4% |
| TBPH | Buy | Theravance Biopharma, Inc. | $4,413,000 | -8.1% | 298,470 | +30.4% | 0.16% | -9.8% |
| NKTR | Nektar Therapeutics | $4,364,000 | -28.4% | 263,079 | 0.0% | 0.16% | -29.3% | |
| PEAK | Healthpeak Properties, Inc. | $4,083,000 | -1.5% | 150,392 | 0.0% | 0.15% | -3.2% | |
| GBT | Global Blood Therapeutics, Inc. | $3,957,000 | -12.6% | 71,759 | 0.0% | 0.15% | -14.0% | |
| SNN | Smith & Nephew plcshares | $3,893,000 | +2.6% | 99,560 | 0.0% | 0.15% | +1.4% | |
| ACHC | Acadia Healthcare Co., Inc. | $3,868,000 | +17.4% | 131,200 | 0.0% | 0.14% | +16.0% | |
| CHRS | Coherus Biosciences, Inc. | $3,725,000 | +2.7% | 203,103 | 0.0% | 0.14% | +1.4% | |
| TAK | Takeda Pharmaceuticsponsored ads | $3,749,000 | -0.5% | 210,146 | 0.0% | 0.14% | -2.1% | |
| AMRN | Amarin Corp. plcsponsored adr | $3,577,000 | -39.2% | 849,588 | 0.0% | 0.13% | -40.2% | |
| ABMD | Sell | ABIOMED, Inc. | $3,383,000 | -11.3% | 12,212 | -22.7% | 0.13% | -12.4% |
| BMYRT | Bristol Myers Squibb Co.right | $3,316,000 | -37.1% | 1,473,710 | 0.0% | 0.12% | -38.3% | |
| ALGN | Align Technology, Inc. | $3,287,000 | +19.3% | 10,041 | 0.0% | 0.12% | +17.1% | |
| KRTX | Buy | Karuna Therapeutics, Inc. | $3,234,000 | -2.9% | 41,827 | +40.0% | 0.12% | -4.7% |
| ARDX | Ardelyx, Inc. | $3,190,000 | -24.1% | 607,698 | 0.0% | 0.12% | -25.0% | |
| ICPT | Intercept Pharmaceuticals, Inc. | $3,195,000 | -13.5% | 77,067 | 0.0% | 0.12% | -14.9% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $3,194,000 | -0.3% | 74,186 | 0.0% | 0.12% | -1.6% | |
| DCPH | Deciphera Pharmaceuticals, Inc. | $3,148,000 | -14.1% | 61,370 | 0.0% | 0.12% | -15.1% | |
| INSM | Insmed Inc. | $3,162,000 | +16.7% | 98,387 | 0.0% | 0.12% | +14.6% | |
| HR | Healthcare Realty Trust Inc. | $3,133,000 | +2.8% | 104,024 | 0.0% | 0.12% | +0.9% | |
| ZLAB | Zai Lab Ltd.adr | $3,121,000 | +1.3% | 37,523 | 0.0% | 0.12% | 0.0% | |
| BNTX | New | BioNTech SEsponsored ads | $3,018,000 | – | 43,595 | +100.0% | 0.11% | – |
| PIRS | Pieris Pharmaceuticals, Inc. | $3,000,000 | -33.2% | 1,449,269 | 0.0% | 0.11% | -34.5% | |
| VRNA | Buy | Verona Pharma plcsponsored adr | $2,967,000 | +151.0% | 475,402 | +87.8% | 0.11% | +146.7% |
| YMAB | Y-mAbs Therapeutics, Inc. | $2,939,000 | -11.1% | 76,548 | 0.0% | 0.11% | -12.7% | |
| ALKS | Alkermes plcshares | $2,816,000 | -14.6% | 169,930 | 0.0% | 0.11% | -15.2% | |
| KDMN | New | Kadmon Holdings, Inc. | $2,799,000 | – | 714,008 | +100.0% | 0.10% | – |
| PHG | Buy | Koninklijke Philips N.V.ny reg sh | $2,684,000 | +2.7% | 56,927 | +2.0% | 0.10% | +2.0% |
| MYOK | MyoKardia, Inc. | $2,631,000 | +41.1% | 19,300 | 0.0% | 0.10% | +39.4% | |
| ZYME | Zymeworks Inc. | $2,606,000 | +29.1% | 55,938 | 0.0% | 0.10% | +27.3% | |
| COGT | New | Cogent Biosciences, Inc. | $2,581,000 | – | 1,103,175 | +100.0% | 0.10% | – |
| MOR | Buy | MorphoSys AGsponsored ads | $2,570,000 | +318.6% | 81,867 | +322.2% | 0.10% | +317.4% |
| ITCI | Intra-Cellular Therapies, Inc. | $2,418,000 | -0.0% | 94,238 | 0.0% | 0.09% | -1.1% | |
| MTEM | Buy | Molecular Templates, Inc. | $2,400,000 | +311.7% | 219,822 | +419.5% | 0.09% | +309.1% |
| THC | Tenet Healthcare Corp. | $2,371,000 | +35.3% | 96,736 | 0.0% | 0.09% | +32.8% | |
| NCNA | New | NuCana plcsponsored adr | $2,382,000 | – | 460,672 | +100.0% | 0.09% | – |
| PRGO | Perrigo Co. plcshares | $2,352,000 | -16.9% | 51,224 | 0.0% | 0.09% | -18.5% | |
| GMRE | Global Medical REIT Inc. | $2,361,000 | +19.1% | 174,897 | 0.0% | 0.09% | +17.3% | |
| QURE | uniQure N.V.shares | $2,322,000 | -18.3% | 63,039 | 0.0% | 0.09% | -19.4% | |
| AXSM | Axsome Therapeutics, Inc. | $2,251,000 | -13.4% | 31,591 | 0.0% | 0.08% | -15.2% | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | $2,228,000 | -11.1% | 34,277 | 0.0% | 0.08% | -12.6% | |
| RVNC | Revance Therapeutics, Inc. | $2,158,000 | +3.0% | 85,840 | 0.0% | 0.08% | +1.2% | |
| HOLX | Hologic, Inc. | $2,165,000 | +16.6% | 32,564 | 0.0% | 0.08% | +14.1% | |
| OVID | Ovid Therapeutics Inc.sponsored adr | $2,139,000 | -22.1% | 372,733 | 0.0% | 0.08% | -23.8% | |
| MEDP | Medpace Holdings, Inc. | $2,109,000 | +20.2% | 18,871 | 0.0% | 0.08% | +17.9% | |
| ALC | Alcon Inc.ordinary shares | $2,089,000 | -0.7% | 36,686 | 0.0% | 0.08% | -2.5% | |
| CLLS | Cellectis S.A.sponsored adr | $2,038,000 | +3.9% | 110,147 | 0.0% | 0.08% | +1.3% | |
| HRTX | Heron Therapeutics, Inc. | $1,944,000 | +0.7% | 131,183 | 0.0% | 0.07% | 0.0% | |
| HTA | Healthcare Trust of America, Inc. | $1,837,000 | -2.0% | 70,662 | 0.0% | 0.07% | -2.8% | |
| BHC | Bausch Health Companies Inc. | $1,840,000 | -15.1% | 118,412 | 0.0% | 0.07% | -15.9% | |
| HARP | New | Harpoon Therapeutics, Inc. | $1,808,000 | – | 106,419 | +100.0% | 0.07% | – |
| KURA | New | Kura Oncology, Inc. | $1,818,000 | – | 59,339 | +100.0% | 0.07% | – |
| ENDP | Endo International plcshares | $1,754,000 | -3.8% | 531,570 | 0.0% | 0.07% | -4.3% | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $1,584,000 | +4.8% | 13,340 | 0.0% | 0.06% | +1.7% | |
| ESPR | Esperion Therapeutics, Inc. | $1,545,000 | -27.6% | 41,577 | 0.0% | 0.06% | -28.4% | |
| MIST | Milestone Pharmaceuticals Inc. | $1,561,000 | +93.7% | 213,310 | 0.0% | 0.06% | +87.1% | |
| EXAS | Sell | Exact Sciences Corp. | $1,545,000 | -59.6% | 15,150 | -65.6% | 0.06% | -60.3% |
| ADUS | Addus HomeCare Corp. | $1,509,000 | +2.1% | 15,969 | 0.0% | 0.06% | +1.8% | |
| INGN | Inogen, Inc. | $1,491,000 | -18.3% | 51,406 | 0.0% | 0.06% | -18.8% | |
| MGTA | Magenta Therapeutics, Inc. | $1,309,000 | -9.4% | 192,431 | 0.0% | 0.05% | -10.9% | |
| NVAX | Sell | Novavax, Inc. | $1,249,000 | -47.5% | 11,523 | -59.6% | 0.05% | -48.4% |
| DHC | Diversified Healthcare Trust | $1,259,000 | -20.5% | 357,720 | 0.0% | 0.05% | -21.7% | |
| DRNA | New | Dicerna Pharmaceuticals, Inc. | $1,226,000 | – | 68,150 | +100.0% | 0.05% | – |
| GSK | Sell | GlaxoSmithKline PLCshares | $1,220,000 | -86.4% | 32,400 | -85.3% | 0.05% | -86.5% |
| ADPT | New | Adaptive Biotechnologies Corp. | $1,202,000 | – | 24,715 | +100.0% | 0.04% | – |
| AVDL | Avadel Pharmaceuticals plcsponsored adr | $1,177,000 | -37.7% | 233,612 | 0.0% | 0.04% | -38.9% | |
| ASRT | Assertio Holdings, Inc. | $1,093,000 | -22.3% | 1,642,302 | 0.0% | 0.04% | -24.1% | |
| XLV | Health Care Select Sector SPDR Fundsbi healthcare | $1,061,000 | +5.5% | 10,055 | 0.0% | 0.04% | +5.3% | |
| SNR | New Senior Investment Group Inc. | $1,026,000 | +10.6% | 256,398 | 0.0% | 0.04% | +8.6% | |
| EIDX | Eidos Therapeutics, Inc. | $1,011,000 | +6.1% | 20,000 | 0.0% | 0.04% | +5.6% | |
| AXNX | Sell | Axonics Modulation Technologies, Inc. | $990,000 | +0.3% | 19,400 | -31.0% | 0.04% | -2.6% |
| KPTI | New | Karyopharm Therapeutics Inc. | $960,000 | – | 65,743 | +100.0% | 0.04% | – |
| GLPG | Galapagos NVsponsored adr | $929,000 | -28.0% | 6,543 | 0.0% | 0.04% | -28.6% | |
| VYNE | New | VYNE Therapeutics Inc. | $899,000 | – | 541,584 | +100.0% | 0.03% | – |
| ACIU | AC Immune SAshares | $838,000 | -27.5% | 171,813 | 0.0% | 0.03% | -29.5% | |
| GRFS | Grifols, S.A.sponsored adr | $822,000 | -4.9% | 47,373 | 0.0% | 0.03% | -6.1% | |
| AERI | Aerie Pharmaceuticals, Inc. | $785,000 | -20.2% | 66,688 | 0.0% | 0.03% | -21.6% | |
| CRBP | Buy | Corbus Pharmaceuticals Holdings, Inc. | $744,000 | -76.6% | 413,481 | +9.2% | 0.03% | -76.9% |
| CHCT | Community Healthcare Trust Inc. | $697,000 | +14.4% | 14,900 | 0.0% | 0.03% | +13.0% | |
| UHT | Universal Health Realty Income Trustshares | $642,000 | -28.3% | 11,258 | 0.0% | 0.02% | -29.4% | |
| CBAY | CymaBay Therapeutics, Inc. | $638,000 | +107.8% | 88,102 | 0.0% | 0.02% | +100.0% | |
| IMGN | ImmunoGen, Inc. | $605,000 | -21.8% | 168,190 | 0.0% | 0.02% | -20.7% | |
| NHI | National Health Investors, Inc. | $605,000 | -0.8% | 10,038 | 0.0% | 0.02% | 0.0% | |
| RGNX | REGENXBIO Inc. | $597,000 | -25.3% | 21,700 | 0.0% | 0.02% | -26.7% | |
| TPTX | Turning Point Therapeutics, Inc. | $496,000 | +35.1% | 5,677 | 0.0% | 0.02% | +35.7% | |
| CYH | Community Health Systems, Inc. | $497,000 | +40.4% | 117,735 | 0.0% | 0.02% | +46.2% | |
| SPPI | Spectrum Pharmaceuticals, Inc. | $468,000 | +20.6% | 114,670 | 0.0% | 0.02% | +20.0% | |
| TCDA | Tricida, Inc. | $456,000 | -67.1% | 50,370 | 0.0% | 0.02% | -67.9% | |
| CLSD | Clearside Biomedical, Inc. | $255,000 | -18.0% | 165,330 | 0.0% | 0.01% | -16.7% | |
| FVE | Five Star Senior Living Inc. | $123,000 | +29.5% | 24,237 | 0.0% | 0.01% | +25.0% | |
| ABIO | ARCA biopharma, Inc. | $143,000 | -33.5% | 32,461 | 0.0% | 0.01% | -37.5% | |
| CLDX | Celldex Therapeutics, Inc. | $105,000 | +14.1% | 7,053 | 0.0% | 0.00% | 0.0% | |
| MNKKQ | Mallinckrodt plcsponsored adr | $32,000 | -63.6% | 32,980 | 0.0% | 0.00% | -66.7% | |
| Bellicum Pharmaceuticals, Inc. | $39,000 | -13.3% | 6,000 | 0.0% | 0.00% | -50.0% | ||
| New | Tetraphase Pharmaceuticals, Inc. | $9,000 | – | 42,965 | +100.0% | 0.00% | – | |
| TTPH | Exit | Tetraphase Pharmaceuticals, Inc. | $0 | – | -42,965 | -100.0% | -0.00% | – |
| ARPO | Exit | Aerpio Pharmaceuticals, Inc. | $0 | – | -257,554 | -100.0% | -0.01% | – |
| CDTX | Exit | Cidara Therapeutics, Inc. | $0 | – | -195,256 | -100.0% | -0.03% | – |
| PBYI | Exit | Puma Biotechnology, Inc. | $0 | – | -71,340 | -100.0% | -0.03% | – |
| Exit | Innate Pharma SAsponsored ads | $0 | – | -137,734 | -100.0% | -0.03% | – | |
| MNLO | Exit | Menlo Therapeutics Inc. | $0 | – | -541,584 | -100.0% | -0.04% | – |
| RUBY | Exit | Rubius Therapeutics, Inc. | $0 | – | -155,982 | -100.0% | -0.04% | – |
| NTLA | Exit | Intellia Therapeutics, Inc. | $0 | – | -55,050 | -100.0% | -0.04% | – |
| KOD | Exit | Kodiak Sciences Inc. | $0 | – | -23,153 | -100.0% | -0.05% | – |
| BBIO | Exit | BridgeBio Pharma, Inc. | $0 | – | -39,228 | -100.0% | -0.05% | – |
| WVE | Exit | WaVe Life Sciences Ltd.shares | $0 | – | -128,146 | -100.0% | -0.05% | – |
| SGMO | Exit | Sangamo Therapeutics, Inc. | $0 | – | -149,835 | -100.0% | -0.05% | – |
| EVH | Exit | Evolent Health, Inc. | $0 | – | -231,027 | -100.0% | -0.06% | – |
| PACB | Exit | Pacific Biosciences of California, Inc. | $0 | – | -495,495 | -100.0% | -0.06% | – |
| HALO | Exit | Halozyme Therapeutics, Inc. | $0 | – | -69,917 | -100.0% | -0.07% | – |
| PTLA | Exit | Portola Pharmaceuticals, Inc.sponsored adr | $0 | – | -109,246 | -100.0% | -0.08% | – |
| AVRO | Exit | AVROBIO, Inc. | $0 | – | -140,581 | -100.0% | -0.09% | – |
| ANAB | Exit | AnaptysBio, Inc. | $0 | – | -118,261 | -100.0% | -0.10% | – |
| QTNT | Exit | Quotient Ltd. | $0 | – | -411,937 | -100.0% | -0.12% | – |
| GWPH | Exit | GW Pharmaceuticals plcads | $0 | – | -25,051 | -100.0% | -0.12% | – |
| EPZM | Exit | Epizyme, Inc. | $0 | – | -207,752 | -100.0% | -0.13% | – |
| LGND | Exit | Ligand Pharmaceuticals Inc. | $0 | – | -30,590 | -100.0% | -0.13% | – |
| PRNB | Exit | Principia Biopharma Inc. | $0 | – | -60,390 | -100.0% | -0.14% | – |
| MNTA | Exit | Momenta Pharmaceuticals, Inc. | $0 | – | -111,768 | -100.0% | -0.14% | – |
| EDIT | Exit | Editas Medicine, Inc. | $0 | – | -130,201 | -100.0% | -0.15% | – |
| XLRN | Exit | Acceleron Pharma Inc. | $0 | – | -40,606 | -100.0% | -0.15% | – |
| INO | Exit | Inovio Pharmaceuticals, Inc. | $0 | – | -202,038 | -100.0% | -0.21% | – |
| RCKT | Exit | Rocket Pharmaceuticals, Inc. | $0 | – | -289,029 | -100.0% | -0.23% | – |
| PTCT | Exit | PTC Therapeutics, Inc. | $0 | – | -120,827 | -100.0% | -0.23% | – |
| ALLO | Exit | Allogene Therapeutics, Inc. | $0 | – | -216,069 | -100.0% | -0.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.